These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15055989)

  • 21. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
    Lee J; Bogyo M
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
    Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
    Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity.
    Rozman-Pungercar J; Kopitar-Jerala N; Bogyo M; Turk D; Vasiljeva O; Stefe I; Vandenabeele P; Brömme D; Puizdar V; Fonović M; Trstenjak-Prebanda M; Dolenc I; Turk V; Turk B
    Cell Death Differ; 2003 Aug; 10(8):881-8. PubMed ID: 12867995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Michael acceptors as cysteine protease inhibitors.
    Santos MM; Moreira R
    Mini Rev Med Chem; 2007 Oct; 7(10):1040-50. PubMed ID: 17979807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
    Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition.
    Schirmeister T; Peric M
    Bioorg Med Chem; 2000 Jun; 8(6):1281-91. PubMed ID: 10896108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
    Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
    Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
    Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
    Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bsmoc group as a novel scaffold for the design of irreversible inhibitors of cysteine proteases.
    Iley J; Moreira R; Martins L; Guedes RC; Soares CM
    Bioorg Med Chem Lett; 2006 May; 16(10):2738-41. PubMed ID: 16503139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
    Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
    Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New m-calpain substrate-based azapeptide inhibitors.
    Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
    J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Click" synthesis of small molecule-peptide conjugates for organelle-specific delivery and inhibition of lysosomal cysteine proteases.
    Loh Y; Shi H; Hu M; Yao SQ
    Chem Commun (Camb); 2010 Nov; 46(44):8407-9. PubMed ID: 20931108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhibitor profiling of the caspase family of proteases using substrate-derived peptide glyoxals.
    Murphy DJ; Walker B; Ryan CA; Martin SL
    Biochem Biophys Res Commun; 2010 Nov; 402(3):483-8. PubMed ID: 20955686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
    Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary lines of cysteine peptidases.
    Barrett AJ; Rawlings ND
    Biol Chem; 2001 May; 382(5):727-33. PubMed ID: 11517925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel azapeptide inhibitors of hepatitis C virus serine protease.
    Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
    J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.
    Micale N; Kozikowski AP; Ettari R; Grasso S; Zappalà M; Jeong JJ; Kumar A; Hanspal M; Chishti AH
    J Med Chem; 2006 Jun; 49(11):3064-7. PubMed ID: 16722625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of cysteine proteases.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.